ReviewJournal of leukocyte biology2016

At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies.

Anthony F O Daniyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.